Concepedia

Kathy Vanderlaag

KV

Statistics

Publications

5

Citations

394

H-Index

5

Active since

2005

Affiliations

Texas A&M University(Current)

Texas A&M Health Science Center

The University of Texas MD Anderson Cancer Center

Scott & White Memorial Hospital

Kathy Vanderlaag is an author at Texas A&M University specializing in oncology, apoptosis, and apoptosis pharmacology.

Publications per year

2005–2010

5

Publications

5

3,3′-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5

Maen Abdelrahim, Kristen Newman, Kathy Vanderlaag et al. · Carcinogenesis · 2005 · 207 citations

, , +17

Oncogenic microRNA‐27a is a target for anticancer agent methyl 2‐cyano‐3,11‐dioxo‐18β‐olean‐1,12‐dien‐30‐oate in colon cancer cells

Sudhakar Chintharlapalli, Sabitha Papineni, Maen Abdelrahim et al. · International Journal of Cancer · 2009 · 123 citations · Full text

, , +17

Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3′-indolyl)methane (DIM) and 5,5′-dibromoDIM

Kathy Vanderlaag, Ismael Samudio, Robert C. Burghardt et al. · Cancer Letters · 2005 · 24 citations

, , +11

1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways

Kathy Vanderlaag, Yunpeng Su, Arthur E. Frankel et al. · Breast Cancer Research and Treatment · 2007 · 21 citations

, , +9

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induce autophagic cell death in estrogen receptor negative breast cancer

Kathy Vanderlaag, Yunpeng Su, Arthur E. Frankel et al. · BMC Cancer · 2010 · 19 citations · Full text

, , +17

1–5 of 5